Eli Lilly And Company Is Scheduled To Present First-Quarter Results – CWEB.com

Eli Lilly and Company (LLY) this week, management is scheduled to present first-quarter results.

Eli Lilly and, Incyte Corporation, meet with the FDA on April 23. The two partners’ new rheumatoid arthritis tablet Olumiant sells to consumers in Europe. Her in the U.S. the FDA rejected an application last year citing evidence suggesting the drug could be linked to dangerous blood clots.

Incyte’s and Elu Lily’s application seven clinical trials that enrolled about 3,100 patients. It was found that Olumiant suppresses the immune system. Five patients in the trial received blood clots. Lilly looks to introduce the drug with a recommended 4 mg dose that tapers down to 2 mg, except for treatment-resistant patients. That would include running a new trial that could take years moving forward. The FDA is looking for more evidence that the drug is safe.

The drug Kevzara introduced by Novartis and Regeneron, Eli Lilly’s competitor are popular in the US. market. Pushing up sales and profits for the company is Eli Lilly’s drug Trulicity reaching 119% higher to $2.0 billion for all of 2018 and accelerated to a $2.6 billion annualized run rate during the last three months of the year.

Lilly Reports Additional Top-Line Results from CYRAMZA ® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer. According to the press release on Eli Lilly’s website- “People with advanced urothelial carcinoma who experience disease progression urgently need treatment options that can control the disease — to help stop or slow the cancer from growing and spreading,” said Levi Garraway, M.D., Ph.D., senior vice president, global development and medical affairs, Lilly Oncology. “Although this study didn’t reach statistical significance for overall survival, we are encouraged by the totality of the RANGE results and look forward to reviewing the data with internal and external experts to determine next steps.”

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping

Sears Is Making A Comeback – CWEB.com

Sears (SHLD) is making a comeback right now and will sustain the momentum going forward.

There will be a conference center that will reside where the old Sears automotive building was and Sears will host an 18,000-square-foot facility selling home goods such as mattresses and appliances. Anything ordered online at  Sears.com  can also be picked up in these store locations. Three new tenants will be leasing a small portion of the Sears building.

For Sears, closing stores can be a path to profitability and beefing up their online presence. Sears has made a deal with Amazon to start selling its Kenmore-branded appliances online that are compatible with Amazon’s Alexa.

Comparing to all other retailers in the industry including Kohls, Costco, Nordstrom, Macys, Walmart, Amazon, Sears holding has a potential turnaround of going over $20-$30 within a year by focusing on shop your way and other new ventures.

Sears Holdings Corporation  (SHLD)  has been named a 2018 ENERGY STAR   ^®Partner of the Year – Sustained Excellence Award winner for continued leadership in protecting our environment through superior energy efficiency achievements. In addition, the Kenmore brand has been named a 2018 ENERGY STAR   ^®Partner of the Year – Product Brand Owner. According to the EPA, it marks the first time a company has won all three awards: Retailer, Energy Management and Brand Owner. Sears Holdings’ and Kenmore’s accomplishments will be recognized by the U.S. Environmental Protection Agency and the U.S. Department of Energy at a ceremony in  Washington, D.C., on  April 20, 2018.

“We truly value Sears Holdings’ partnership with ENERGY STAR and are honored to receive the Partner of the Year Award in Sustained Excellence for the ninth consecutive year in Retail and the seventh consecutive year in Energy Management,” said  Edward S. Lampert, chairman and chief executive officer of Sears Holdings. “Being recognized by ENERGY STAR as a retail leader only further increases our members’ trust in us to continuously provide energy-efficient solutions that meet their needs. We remain committed to continuing our work to help increase energy efficiency, to offer savings to our members, and to protect the environment through our dedicated efforts.”

CWEB Analyst’s have initiated a Buy Rating for  Sears (SHLD)      

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping

CWEB.com – Johnson & Johnson Beats Earnings Estimates

By Leslie Cohen
Managing Editor

Johnson & Johnson (NYSE: JNJ) Johnson & Johnson’s first-quarter earnings beat and exceeded expectations on 4-17-2018. With a lot of momentum carrying from 2017 to 2018, the results were positive.

Earnings came out at: $2.06 per share vs. $2.02 per share expected. Respectively, revenue topped to $20 billion vs. $19.46 billion that was expected.

The new US tax legislation law gives J&J more flexibility to invest on a global basis and within the US. Strong investments of 30 billion dollars over a four year period will occur in new technologies that will be manufactured in the US.

Johnson & Johnson’s role as a biotech buyer gives them a fifty percent growth rate for the company. J&J’s consumer business has lagged with the other occupants in this sector. Baby care product sales fell down to $457 million from $455 million, a 3% percent decrease year-over-year when excluding currency. J&J will relaunch its baby care later this year. The millennial age group is interested more in organic products. With competition heating up from other organic companies like “The Honest Company”, J&J will introduce a line of baby care items with organic ingredients.

Sales for Xarelto, the blood thinner medication rose approximately 13 percent on an operational basis reaching only $578 million in global sales, missing analysts’ estimates of $633.7 million. Sales worldwide fell down to 18 percent, excluding a positive currency impact, to $1.34 billion, therefore missing analysts’ expectations for sales of $1.5 billion.

Remicade drug for arthritis has been under pressure with generic versions on the market. On the bright side the Food and Drug Administration approved Erleada, a drug that treats non-metastatic castration-resistant prostate cancer.

Chief Financial Officer Dominic Caruso CFO is announcing his retirement from his 12 year tenure at Johnson & Johnson.

JNJ  data by  YCharts

CWEB – Barbara Bush, In Failing Health, Says She Won’t Seek Further Treatment

By Leslie Cohen
Managing Editor

Former first lady of former President George H. W. Barbara Bush is in failing health. She has been suffering from Chronic Obstructive Pulmonary Disease, (COPD), and congestive heart failure.

Her diseases have progressed in the past couple of days. She has opted for care at home and has decided not to return to the hospital. This is a very difficult time for the family. Former President George H. W. Bush and their daughter Doro, along with her sons Marvin and Neil are at her bedside.

Barbara Bush wife of George H. W. Bush, served as the 37th First Lady of the United States from 1989 to 1993. Since the Former President George W. Bush left the White House, they have raises more than a billion dollars for charity, specifically for the of cause of literacy.

Former President George H.W Bush quotes in his book, “All the Best” “We are two people, but we are one.” The two have been married for 73 years.

We wish the Bush Family our sincere prayers at this difficult time.

CWEB – Uber Wins Landmark Victory in Federal Court

By Leslie Cohen
Managing Editor

Uber Technologies Inc. the peer-to-peer ridesharing just has just had a landmark victory when a federal judge U.S. District Judge Michael Baylson ruled Thursday, April 12th, 2018, that UberBlack drivers will not be classified as employees. Razak v. Uber Technologies was filed in February 2016.   The ruling states that under the Fair Labor Standards Act, Uber does not maintain enough control over the drivers, and they will be classified as independent contractors. This is the first case in the ridesharing segment of the new economy.

Judge Baylosn stated that since the drivers make their own hours, they are not employees under the Fair Labor Standards Act guidelines.

Uber drivers do not get the benefits of workers who are full-time employees that can receive health insurance, 401K plans, vacation time, and other benefits that come with full-time employment.

Jeremy Abay, one of the lawyers for the plaintiffs will appeal the decision in Philadelphia-based 3rd U.S. Circuit Court of Appeals. Should the appeal fail, the ruling could set precedence for the entire ride-sharing industry and the associated gig economy.

Sprint And T- Mobile Merger Talks Begin – CWEB.com

By: Leslie Cohen
Managing Editor

Sprint Corp. (S)and T-Mobile US Inc. (TMUS) have rekindled merger talks. After four years, the two companies that have been fierce rivals are exploring a combination for the third time in four years.

Shares of Sprint Corp.  (S)  , +18.00% spiked higher in midday trade, Tuesday 4/10/2018. Last time, merger talks were left in disarray after the companies could not agree on who would take control over the combined entity. Japan’s Softbank Corp. owns about 85 percent of Sprint and T-Mobile  (TMUS)  is controlled by Germany’s Deutsche Telekom AG.

Looking to expand into the 5G wireless technology, a merger between Sprint    (S)  at T- Mobile  (TMUS)  can give it an edge to compete and serve 127 million customers if combined. Sprint stated back in March that $6 billion annually, over the next several fiscal years would need to be spent on upgrades.

While under CEO Marcelo Claure, states Sprints growth has occurred due to massive and heavy discounting. It looks like Sprint just can’t get up to scale without a T- Mobile partnership.

Regulatory- and antitrust hurdles would exist under the current political climate with a Sprint- T- Mobile merger. The merger between AT&T Inc.(T) – and Time Warner Inc. (TWX) – is up against hurdles, and fighting this battle in court.

CWEB Analyst’s have initiated a Hold Rating for  Sprint Corp. (S)  , and a Price Target of $5.40    

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping

Boeing Delivers – CWEB.com

By Leslie Cohen
Managing Editor

Boeing Co. U.S.: (BA) was able to deliver record setting results for commercial aircraft deliveries in 2017. The tax law changes implemented by President Trump have given Boeing the ability to invest billions of dollars into its business.

Lion Air Group, the budget airline based in Indonesia announced Tuesday the order for 50 Boeing Co. 737 Max 10 jets, adding more seats to its planes with the growth of travel in the country. The contract is worth $6.24 billion.

Boeing increases first-quarter deliveries by nearly 9 percent. It has acquired $11.5 billion in free cash flow. We could see an upside of 20%-25% annual growth over the next five years.

As of April 10^thmany top analysts rate it a buy including Cowen % Company, Edward Jones, Jeffries and Co., JP. Morgan Securities and Morgan Stanley.

CWEB Analyst’s have initiated a Buy Rating for  Boeing Co. U.S.: (BA), and a Price Target of $400 within 12 months.

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping

Reasons To Consider General Motors A Buy – CWEB.com

General Motors (GM) has    an impressive dividend yield that has free cash flow support.

GM outperformed the domestic automakers in January.

GM outsold more light trucks than Ford.

With a robust portfolio of electric vehicles projected over the next half decade, GM is positioned at the front of the pack in this rapidly growing space.

General Motors  (GM)  shares enjoy enormous upside potential due to record-setting profitability, robust free cash flow generation, reduced correlation to the overall North American automotive market, a strong position in electric cars and huge business in China.

GM China (NYSE:GM) reports sales increased 2.0% in March to 352,346 units.

Cadillac sales rose 46% to 18K units (monthly record) to help offset drops for the Wuling and Baojun brands.

GM China YTD sales +7.9% to 986,052 units.

General Motors reported superb March results for the U.S. market. Crossover and pickup demand is strong and will likely continue to support GM in a rising economy that is accompanied by cyclical consumer spending growth.

CWEB Analyst’s Reiterates a Buy Rating for  General Motors (GM) and Price Target of $59 within 12 months

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping

Viacom Reject Takeover Offer From CBS Below Its $12.5 Billion Valuation – CWEB.com

By: Leslie Cohen

Managing Editor

CBS Corp. (CBS) makes an offer for Viacom with an all stock purchase offer with the contingency it keeps it the same management team leading the organization- at least for now. Viacom’s (VIA)  current valuation is $12.5 billion. Viacom rejected this offer of 0.55 shares of CBS in an all-stock deal for each share of Viacom.

CBS proposes that eventually current CEO Bob Bakish would no longer run the company, and that Chief Executive Leslie Moonves and President Joe Ianniello would run the combined company for the foreseeable future.

Sumner Redstone’s holding company National Amusements Inc., holds an 80% voting stake in CBS and Viacom Redstone’s daughter, Shari Redstone has wanted the two companies to be combined for quite some time.

CBS  (CBS)  shares have not been rising. Viacom    (VIA)  is still valued at a bargain with 8x forward P/E with a firm grip on streaming and content development plans moving forward.

While Viacom is a value stock at this point valued at less than 10 times earnings, it also carries an array of impressive brands owning Global Entertainment Group which broadcasts The Comedy Chanel, Spike, MTV, and Nickelodeon. It also has a sweet deal coming up with Netflix for streaming content. Viacom’s assets also include Paramount Pictures Corporation, BET Networks is a division of Viacom that runs the Black Entertainment Television (BET) channel, Nick Records and Comedy Central Records

Viacom’s huge library of iconic brands, and the fact that the company plans to start a Netflix (NASDAQ:NFLX) style streaming service in the near future, are all compelling arguments to buying into a beaten-down value stock at less than 10 times forward earnings and the fact that is looks to grow in the online streaming market.

CBS has been has lost more than 23% in the past year, but still ahead of its peers. Viacom shares are down32%.

CWEB Analyst’s Reiterates a Hold Rating for CBS Corp. (CBS)  

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping

[object HTMLElement]

Is Kraft Heinz A Buy At This Levels – CWEB.com

Shares of The Kraft Heinz Company (KHC) have had a rough year.

With high $90s almost a year ago, shares are at 52-week lows trading around $63.

The brand portfolio is robust, and the dividend is yielding much higher than historical norms.

Organic growth is weak, likely due to the company’s lack of expansion efforts outside of North America.

The yield is highly competitive, but is likely not enough of a buffer in the short term.

Kraft Heinz  (KHC)  ended 2017 on a softer note after the third-quarter results provided reasons to become more upbeat.

The only bright news is the fact that the valuation has continuously come down, reducing expectations along the way.

Company has started to aggressively pay down debt.

Interest rate on the debt is 3.8%, which is an expense that will not impede future dividend increases.

The dividend has increased an average 12% per year since 2013.

Even if we reduce future dividend growth by 25%, our growth model still shows a 9.14% total annual return to 2021.

CWEB Analyst’s have initiated a Buy Rating for  Kraft Heinz Company (KHC) and a Price Target of $90 within 12 months.

Read Full Article and Videos  CWEB.com – Trending News, Blog, Shopping